|
Neurometrix Inc (NASDAQ: NURO) |
|
Neurometrix Inc
NURO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Neurometrix Inc 's sales fell
by -51.19 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2152
Medical Equipment & Supplies industry recorded
growth of revenues by 1.68 %
Neurometrix Inc net loss decreased from $-2 millions, to $-2 millions in III. Quarter 2024,
• More on NURO's Growth
|
|
Neurometrix Inc realized a net loss in trailing twelve months.
Neurometrix Inc realized cash reduction of $ -0.27 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.79.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.29.
• More on NURO's Valuation
|
|
|
|
|
Neurometrix Inc realized net loss in trailing twelve months.
Neurometrix Inc realized cash outflow of $ -0.27per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.79.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.29.
Neurometrix Inc Price to Book Ratio is at 0.49 higher than Industry Avg. of -564.72, and higher than S&P 500 Avg. of 0.01
• More on NURO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com